(TALK) Talkspace - Overview
Sector: Healthcare | Industry: Health Information Services | Exchange: NASDAQ (USA) | Market Cap: 871m USD | Total Return: 55.2% in 12m
Avg Turnover: 7.84M
Qual. Beats: 0
Rev. Trend: 99.2%
Qual. Beats: -1
Warnings
Beneish M-Score -0.93 > -1.5 - likely earnings manipulation
Altman Z'' -14.25 < 1.0 - financial distress zone
Tailwinds
Rs Leader, Idiosyncratic Leader, Tailwind
Talkspace, Inc. (TALK) is a New York-based virtual behavioral healthcare provider that facilitates psychotherapy and psychiatry services through a proprietary digital platform. The company utilizes a multi-channel delivery model, offering clinical sessions via asynchronous messaging, synchronous audio, and live video. Its business strategy focuses on a diversified payer mix, including direct-to-consumer subscribers, enterprise partnerships, and integrated health insurance networks.
The behavioral health sector has transitioned significantly toward telehealth, as virtual care reduces traditional barriers such as geographic limitations and provider shortages. Talkspace operates within the telehealth and health care technology space, where scalability depends on securing large-scale contracts with employee assistance programs (EAPs) and national insurance carriers. Investors can find further valuation metrics and peer comparisons on ValueRay. This shift toward business-to-business (B2B) revenue streams aims to lower customer acquisition costs compared to traditional direct-to-consumer models.
- Expansion of covered lives through health insurance and enterprise partnerships
- Shift from direct-to-consumer to high-margin B2B revenue mix
- Profitability milestones and operating leverage drive investor sentiment
- Federal and state reimbursement rates for virtual behavioral health services
- Rising demand for mental health services amid therapist labor shortages
| Net Income: 1.17m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.05 > 0.02 and ΔFCF/TA -9.83 > 1.0 |
| NWC/Revenue: 36.79% < 20% (prev 54.02%; Δ -17.24% < -1%) |
| CFO/TA 0.04 > 3% & CFO 5.36m > Net Income 1.17m |
| Net Debt/EBITDA: error (cannot be calculated) |
| Current Ratio: 4.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (173.8m) vs 12m ago -1.02% < -2% |
| Gross Margin: 42.24% > 18% (prev 0.45%; Δ 4.18k% > 0.5%) |
| Asset Turnover: 176.3% > 50% (prev 144.8%; Δ 31.50% > 0%) |
| Interest Coverage Ratio: 1.89 > 6 (EBITDA TTM 6.20m / Interest Expense TTM 945k) |
| A: 0.64 (Total Current Assets 110.5m - Total Current Liabilities 22.8m) / Total Assets 136.2m |
| B: -1.97 (Retained Earnings -267.7m / Total Assets 136.2m) |
| C: 0.01 (EBIT TTM 1.78m / Avg Total Assets 135.2m) |
| D: -11.57 (Book Value of Equity -267.8m / Total Liabilities 23.1m) |
| Altman-Z'' = -14.25 = D |
| DSRI: 1.45 (Receivables 23.6m/13.2m, Revenue 238.4m/194.4m) |
| GMI: 1.07 (GM 42.24% / 45.02%) |
| AQI: 3.59 (AQ_t 0.06 / AQ_t-1 0.02) |
| SGI: 1.23 (Revenue 238.4m / 194.4m) |
| TATA: -0.03 (NI 1.17m - CFO 5.36m) / TA 136.2m) |
| Beneish M = -0.93 (Cap -4..+1) = D |
As of June 01, 2026, the stock is trading at USD 5.20 with a total of 2,858,348 shares traded.
Over the past week, the price has changed by +0.19%,
over one month by +0.19%,
over three months by +5.48% and
over the past year by +55.22%.
Talkspace has received a consensus analysts rating of 4.71. Therefore, it is recommended to buy TALK.
- StrongBuy: 6
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 6.2 | 18.3% |
P/E Forward = 43.29
P/S = 3.6543
P/B = 7.69
Revenue TTM = 238.4m USD
EBIT TTM = 1.78m USD
EBITDA TTM = 6.20m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 786.9m USD (871.1m + (null Debt) - CCE 84.2m)
Interest Coverage Ratio = 1.89 (Ebit TTM 1.78m / Interest Expense TTM 945k)
EV/FCF = -121.2x (Enterprise Value 786.9m / FCF TTM -6.49m)
FCF Yield = -0.83% (FCF TTM -6.49m / Enterprise Value 786.9m)
FCF Margin = -2.72% (FCF TTM -6.49m / Revenue TTM 238.4m)
Net Margin = 0.49% (Net Income TTM 1.17m / Revenue TTM 238.4m)
Gross Margin = 42.24% ((Revenue TTM 238.4m - Cost of Revenue TTM 137.7m) / Revenue TTM)
Gross Margin QoQ = 41.53% (prev 42.74%)
Tobins Q-Ratio = 5.78 (Enterprise Value 786.9m / Total Assets 136.2m)
Interest Expense / Debt = unknown (Interest Expense 945k / Debt none)
Taxrate = 6.86% (574k / 8.37m)
NOPAT = 1.66m (EBIT 1.78m * (1 - 6.86%))
Current Ratio = 4.84 (Total Current Assets 110.5m / Total Current Liabilities 22.8m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 6.20m)
Debt / FCF = unknown (Net Debt none / FCF TTM -6.49m)
Total Stockholder Equity = 113.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.86% (Net Income 1.17m / Total Assets 136.2m)
RoE = 0.31% (Net Income TTM 1.17m / Total Stockholder Equity 380.8m)
RoCE = 1.57% (EBIT 1.78m / Capital Employed (Total Assets 136.2m - Current Liab 22.8m))
RoIC = 5.70% (NOPAT 1.66m / Invested Capital 29.2m)
WACC = 9.40% (E(871.1m)/V(871.1m) * Re(9.40%) + (debt-free company))
Discount Rate = 9.40% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 13.80 | Cagr: 0.54%
[DCF] Fair Price = unknown (Cash Flow -6.49m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 99.20 | Revenue CAGR: 23.97% | SUE: -2.72 | # QB: -1
EPS current Quarter (2026-06-30): EPS=0.03 | Chg30d=N/A | Revisions=N/A | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.04 | Chg30d=-8.25% | Revisions=N/A | Analysts=3
EPS current Year (2026-12-31): EPS=0.14 | Chg30d=-8.87% | Revisions=+20% | GrowthEPS=+241.7% | GrowthRev=+21.5%
EPS next Year (2027-12-31): EPS=0.22 | Chg30d=-8.33% | Revisions=+20% | GrowthEPS=+61.0% | GrowthRev=+23.6%
[Analyst] Revisions Ratio: +20%